Surface functionalization of SBA-15 nanorods for anticancer drug delivery

Chemical Engineering Research and Design

Volumn 92, Issue 7, 2014, Pages 1296-1303

  Bahrami, Zohreh ^a   Badiei, Alireza ^a   Atyabi, Fatemeh ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticancer drug delivery; Gemcitabine; Nanorods; Organotrialkoxy silane; SBA 15; Surface functionalization

Indexed keywords

ADSORPTION; DRUG DELIVERY; DRUG PRODUCTS; SILANES; ULTRAVIOLET SPECTROSCOPY;

ADSORPTION/DESORPTION; ANTI-CANCER DRUG DELIVERY; GEMCITABINE; HIGH SURFACE AREA; MESOPOROUS MATRIX; PH-DEPENDENT RELEASE; SBA-15; SURFACE FUNCTIONALIZATION;

NANORODS;

EID: 84903450716     PISSN: 02638762     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cherd.2013.11.007     Document Type: Article

References (46)

1. Balas F., Manzano M., Horcajada P., Vallet-Regí M. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J. Am. Chem. Soc. 2006, 128(25):8116-8117.
2. Barbé C., Bartlett J., Kong L., Finnie K., Lin H.Q., Larkin M., Calleja S., Bush A., Calleja G. Silica particles: a novel drug-delivery system. Adv. Mater. 2004, 16:1949-1966.
3. Braakhuis B.J., Dongen G.A.v., Vermorken J.B., Snow G.B. Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (gemcitabine) against human head and neck cancer. Cancer Res. 1991, 51:211-214.
4. Burris H., Storniolo A.M. Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil. Eur. J. Cancer 1997, 33:S18-S22.
5. Cariono I.S., Pasqua L., Testa F., Aiello R., Puoci F., Iemma F., Picci N. Silicabased mesoporous materials as drug delivery system for methotrexate release. Drug Deliv. 2007, 14:491-495.
6. Chen Z., Li X., He H., Ren Z., Liu Y., Wang J., Li Z., Shen G., Han G. Mesoporous silica nanoparticles with manipulated microstructures for drug delivery. Colloids Surf., B 2012, 95:274-278.
7. Doadrio A.L., Sousa E.M., Doadrio J.C., Perez Pariente J., Izquierdo-Barba I., Vallet-Regí M. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. J. Control. Release 2004, 97(1):125-132.
8. Gao L., Sun J., Li Y. Functionalized bimodal mesoporous silicas as carriers for controlled aspirin delivery. J. Solid State Chem. 2011, 184(8):1909-1914.
9. Gary-Bobo M., Hocine O., Brevet D., Maynadier M., Raehm L., Richeter S., Charasson V., Loock B., Morere A., Maillard P., Garcia M., Durand J.O. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. Int. J. Pharm. 2012, 423(2):509-515.
10. Gu J., Su S., Zhu M., Li Y., Zhao W., Duan Y., Shi J. Targeted doxorubicin delivery to liver cancer cells by PEGylated mesoporous silica nanoparticles with a pH-dependent release profile. Microporous Mesoporous Mater. 2012, 161:160-167.
11. Heikkila T., Salonen J., Tuura J., Hamdy M.S., Mul G., Kumar N., Salmi T., Murzin D.Y., Laitinen L., Kaukonen A.M., Hirvonen J., Lehto V.P. Mesoporous silica material TUD-1 as a drug delivery system. Int. J. Pharm. 2007, 331:133-138.
12. Hu Y., Wang J., Zhi Z., Jiang T., Wang S. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug. J. Colloid Interface Sci. 2011, 363(1):410-417.
13. Izquierdo-Barba I., Martinez A., Doadrio A.L., Perez-Pariente J., Vallet-Regi M. Release evaluation of drugs from ordered three-dimensional silica structures. Eur. J. Pharm. Sci. 2005, 26(5):365-373.
14. Izquierdo-Barba I., Sanchez-Salcedo S., Colilla M., Feito M.J., Ramirez-Santillan C., Portoles M.T., Vallet-Regi M. Inhibition of bacterial adhesion on biocompatible zwitterionic SBA-15 mesoporous materials. Acta Biomater. 2011, 7(7):2977-2985.
15. Jaroniec C.P., Kruk M., Jaroniec M., Sayari A. Tailoring surface and structural properties of MCM-41 silicas by bonding organosilanes. J. Phys. Chem. B 1998, 102(28):5503-5510.
16. Kruk M., Jaroniec M., Ko C.H., Ryoo R. Characterization of the porous structure of SBA-15. Chem. Mater. 2000, 12:1961-1968.
17. Lai C.Y., Trewyn B.G., Jeftinija D.M., Jeftinija K., Xu S., Jeftinija S., Lin V.S. A mesoporous silica nanosphere-based carrier system with chemically removable cds nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 2003, 125(15):4451-4459.
18. Lee H.I., Kim J.H., Stucky G.D., Shi Y., Pak C., Kim J.M. Morphology-selective synthesis of mesoporous SBA-15 particles over micrometer, submicrometer and nanometer scales. J. Mater. Chem. 2010, 20(39):8483.
19. Moritz M., Łaniecki M. SBA-15 mesoporous material modified with APTES as the carrier for 2-(3-benzoylphenyl)propionic acid. Appl. Surf. Sci. 2012, 258(19):7523-7529.
20. Munoz B., Ra↠mila A., Pe↠rez-Pariente J., Di↠az I., Vallet-Regi M. MCM-41 organic modification as drug delivery rate regulator. Chem. Mater. 2003, 15:500-503.
21. Nieto A., Balas F., Colilla M., Manzano M., Vallet-Regí M. Functionalization degree of SBA-15 as key factor to modulate sodium alendronate dosage. Microporous Mesoporous Mater. 2008, 116(1-3):4-13.
22. Nieto A., Colilla M., Balas F., Vallet-Regi M. Surface electrochemistry of mesoporous silicas as a key factor in the design of tailored delivery devices. Langmuir 2010, 26(7):5038-5049.
23. Nunes C.D., Vaz P.D., Fernandes A.C., Ferreira P., Romäo C.C., Calhordo M.J. Loading and delivery of sertraline using inorganic micro and mesoporous materials. Eur. J. Pharm. Biopharm. 2007, 66:357-365.
24. Patra C.R., Bhattacharya R., Mukhopadhyay D., Mukherjee P. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv. Drug Deliv. Rev. 2010, 62(3):346-361.
25. Prokopowicz M., Przyjazny A. Synthesis of sol-gel mesoporous silica materials providing a slow release of doxorubicin. J. Microencapsul. 2007, 24:694-713.
26. Qu F., Zhu G., Huang S., Li S., Sun J., Zhang D., Qiu S. Controlled release of captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous Mesoporous Mater. 2006, 92(1-3):1-9.
27. Sevimli F., Yilmaz A. Surface functionalization of SBA-15 particles for amoxicillin delivery. Microporous Mesoporous Mater. 2012, 15:8281-8291.
28. Shen S.C., Ng W.K., Chia L., Hu J., Tan R.B. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size. Int. J. Pharm. 2011, 410(1-2):188-195.
29. Socrates G. Infrared and Raman Characteristic Group Frequencies: Tables and Charts 2004, John Wiley& Sons, Ltd.
30. Song S.W., Hidajat K., Kawi S. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions. Langmuir 2005, 21(21):9568-9575.
31. Tang Q., Xu Y., Wu D., Sun Y. A study of carboxylic-modified mesoporous silica in controlled delivery for drug famotidine. J. Solid State Chem. 2006, 179(5):1513-1520.
32. Tourné-Péteilh C., Lerner D.A., Charnay C., Nicole L., Begu S., Devoisselle J.M. The potential of ordered mesoporous silica for the storage of drugs: the example of a pentapeptide encapsulated in aMSU-Tween 80. Chem. Phys. Chem. 2003, 4:281-286.
33. Tozuka Y., Sugiyama E., Takeuchi H. Release profile of insulin entrapped on mesoporous materials by freeze-thaw method. Int. J. Pharm. 2010, 386:172-177.
34. Tsai C.-P., Hung Y., Chou Y.-H., Huang D.-M., Hsiao J.-K., Chang C., Chen Y.-C., Mou C.-Y. High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe. Small 2008, 4(2):186-191.
35. Vallet-Regi M. Nanostructured mesoporous silica matrices in nanomedicine. J. Intern. Med. 2010, 267(1):22-43.
36. Vallet-Regí M. Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin. Solid State Ionics 2004, 172(1-4):435-439.
37. Vallet-Regi M., Balas F., Arcos D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed. 2007, 46(40):7548-7558.
38. Vallet-Regí M., Rámila A., Real R.P.d., Pérez-Pariente J. A new property of MCM-41: drug delivery system. Chem. Mater. 2001, 13:308-311.
39. Vallet-Regí M., Ruiz-González L., Izquierdo-Barba I., Gonzalez-Callbet J.M. Revisiting silica based ordered mesoporous materials: medical application. J. Mater. Chem. 2006, 16:26-31.
40. Vallet-Regí M., Balas F., Colilla M., Manzano M. Bone-regenerative bioceramic implants with drug and protein controlled delivery capability. Prog. Solid State Chem. 2008, 36(3):163-191.
41. Xu W., Gao Q., Xu Y., Wu D., Sun Y., Shen W., Deng F. Controlled drug release from bifunctionalized mesoporous silica. J. Solid State Chem. 2008, 181(10):2837-2844.
42. Xu Y., Qu F., Wang Y., Lin H., Wu X., Jin Y. Construction of a novel pH-sensitive drug release system from mesoporous silica tablets coated with Eudragit. Solid State Sci. 2011, 13(3):641-646.
43. Yang L.M., Wang Y.J., Luo G.S., Dai Y.Y. Functionalization of SBA-15 mesoporous silica with thiol or sulfonic acid groups under the crystallization conditions. Microporous Mesoporous Mater. 2005, 84(1-3):275-282.
44. Yuan L., Tang Q., Yang D., Zhang J.Z., Zhang F., Hu J. Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery. J. Phys. Chem. C 2011, 115(20):9926-9932.
45. Zhao D.Y., Feng J.L., Huo Q.S., Melosh N., Fredrickson G.H., Chmelka B.F., Stucky G.D. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 1998, 279:548-552.
46. Zhuravlev L.T. The surface chemistry of amorphous silica. Zhuravlev model. Colloids Surf., A 2000, 173(1-3):1-38.